Identification of drug metabolites in human plasma or serum integrating metabolite prediction, LC–HRMS and untargeted data processing

By Jacobs Peter L   Ridder Lars   Ruijken Marco   Rosing Hilde   Jager Nynke GL   Beijnen Jos H   Bas Richard R   van Dongen William D  

Bioanalysis, Vol. 5, Iss. 17, 2013-09 ,pp. : 2115-2128

Future Science

Access to resources Recommend Favorite

Analysis of Human Plasma Proteome by 2DE‐ and 2D nanoLC‐Based Mass Spectrometry

By Choi Kyoung   Song Liguo   Park Young   Marshall James   Lund Anders   Shion Henry   Park Eun   Chae Ho   Park Jong Hoon  

Preparative Biochemistry & Biotechnology, Vol. 36, Iss. 1, 2006-02 ,pp. : 3-17

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pegasparaginase: where do we stand?

By Zeidan Amer   Wang Eunice S   Wetzler Meir  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 1, 2009-01 ,pp. : 111-119

Informa Healthcare

Access to resources Recommend Favorite

Structure and function of xanthine oxidoreductase: where are we now?

By Harrison R.  

Free Radical Biology and Medicine, Vol. 33, Iss. 6, 2002-09 ,pp. : 774-797

Elsevier

Access to resources Recommend Favorite

Immunotherapy and immunoprevention of cancer: where do we stand?

By Cavallo Federica   Curcio Claudia   Forni Guido  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 5, 2005-05 ,pp. : 717-726

Informa Healthcare

Access to resources Recommend Favorite